Ultragenyx Q2 FY26 net loss narrows to $92 million; revenue rises to $214 million
Reuters2026/08/04 20:31- Ultragenyx Q2 revenue rose 28.14% to $214 million; net loss narrowed to $92 million from $115 million.
- Crysvita revenue increased to $156 million from $121 million; Dojolvi revenue climbed to $27 million from $23 million.
- Operating expenses grew to $289 million from $275 million; cash, cash equivalents, and marketable securities totaled $436 million at June 30.
- Reaffirmed 2026 revenue guidance of $730 million-$760 million, excluding potential new launches; targets profitability in 2027.
- FDA set PDUFA dates for DTX401 on Aug. 23, 2026, and UX111 on Sept. 19, 2026; Phase 3 Aspire data for GTX-102 expected in September or October.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Colgate-Palmolive (CL.US) plans to sell part of its personal care brands, with a total transaction amount possibly exceeding 1.1 billions USD.
According to sources familiar with the matter, Colgate is exploring the sale of some of its mass-market personal care brands. The company currently plans to divest only a few brands within its personal care business, and the combined sale price may exceed 1 billion dollars.
EdiliziAcrobatica announces shareholder meeting notice
Storage Giant Offers Huge Bonuses Again: Micron Awards Up to 68 Months’ Bonus
Micron Technology has announced record-breaking bonuses for its employees in Taiwan, ranging from 35 to 68 months’ salary, with a minimum cash compensation of 1.7 million New Taiwan dollars. However, the Taoyuan union, representing about two-thirds of Micron’s workers in Taiwan, has refused to accept the offer, insisting that 15% of operating profits be included in the bonus distribution and maintaining the threat of a strike.
Crypto prices
More
